Yale School of Medicine scientists to study whether vaccine could ease symptoms of COVID-19 'long-haulers'
Scientists at Yale School of Medicine launched a new study Friday to see whether vaccines can ease the symptoms of COVID-19 "long-haulers."
•
Apr 30, 2021, 9:19 PM
•
Updated 1,183 days ago
Share:
More Stories
Hometown Heroes in Connecticut
100ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago0:29
Connecticut health commissioner fired during COVID settles with state; dismissal now a resignation
304ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
310ds ago2:00
Should you get a COVID booster? Hartford Healthcare doctor says wait
331ds ago0:22
Nearly 200 Stamford small businesses to receive COVID-19 relief grants
350ds agoHometown Heroes in Connecticut
100ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago0:29
Connecticut health commissioner fired during COVID settles with state; dismissal now a resignation
304ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
310ds ago2:00
Should you get a COVID booster? Hartford Healthcare doctor says wait
331ds ago0:22
Nearly 200 Stamford small businesses to receive COVID-19 relief grants
350ds agoScientists at Yale School of Medicine launched a new study Friday to see whether vaccines can ease the symptoms of COVID-19 "long-haulers."
The so-called long-hauler syndrome leaves up to 10% of COVID-19 patients with symptoms months after infection.
Researchers say the causes are still unclear. They are looking for long-haulers to participate who haven't been vaccinated yet.
VACCINE APPOINTMENTS: Get appointment information
Professor Akiko Iwasaki says the inspiration for the study started on social media. Informal polling from patient groups like Survivor Corps found about 40% of long-haulers were feeling better after the vaccine.
Other patients reported feeling the same or worse. Now, researchers want to find out what's causing some long-haulers to make a recovery.
Iwasaki hopes that data will help create new therapies and give long-haulers hope.
Participants will give blood samples before vaccination and again at six and 12 weeks after their first shot.
